All posts by PIER MARIA FORNASARI

PIER MARIA FORNASARI
2024-05-25

Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer

Combining immune-targeted therapy with chemotherapy improves both progression-free survival and overall survival when compared to those who received regorafenib alone A study(Link is external) (Link opens in new window) led by UCLA Health Jonsson Comprehensive Cancer Center(Link opens in new window) researchers found that using a combination of experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall survival

Read More

No Comments InCANCER IMMUNOTHERAPY
PIER MARIA FORNASARI
2024-05-22

Exercise should be prescribed for people with Parkinson’s: Aarhus University Researchers find

Based on a new study from Aarhus University, researchers recommend that exercise be considered as medicine for Parkinson’s disease and that it should be prescribed as a supplement as early as possible. No pharmacological medication currently available can cure or slow down Parkinson’s disease. However, based on an extensive literature review recently published in the

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2024-05-11

COVID-19 vaccine can help people with heart failure live longer

Heart failure patients who are vaccinated against COVID-19 have an 82% greater likelihood of living longer than those who are not vaccinated, according to research presented today at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).1 Heart Failure is a life-threatening syndrome affecting more than 64 million people worldwide.2 “Patients with

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2024-05-11

Regeneron Presents Update on Gene Therapy for Genetic Deafness at ASGCT

Regeneron presented results from an ongoing Phase I/II clinical trial for its investigational gene therapy, DB-OTO, at the annual American Society of Gene and Cell Therapy (ASGCT) meeting, being held in Baltimore, Md. from May 7–11. DB-OTO, a gene therapy for genetic deafness, improved hearing in one child, treated at 11 months old to normal levels within

Read More

No Comments InGENE THERAPY RARE DISEASES
PIER MARIA FORNASARI
2024-05-11

Fred Hutch scientist Dr. Adair partners with colleagues around the globe to make gene therapies more effective and more widely available

Fred Hutch Cancer Center scientist Jennifer E. Adair, PhD, is on a mission to foster worldwide collaboration on potentially curative gene therapies. Holder of the Fleischauer Family Endowed Chair in Gene Therapy Translation, Adair just co-authored two articles published today in Science Translational Medicine as part of a special series on global access to these therapies that she

Read More

No Comments InGENE THERAPY RARE DISEASES
PIER MARIA FORNASARI
2024-05-11

Autoantibody associated dermatomyositis and Interstitial Pneumonitis: an Entirely New COVID-Related Syndrome.

UC San Diego joins forces with UK researchers in a retrospective observational study to solve a medical mystery. Pradipta Ghosh, M.D., sat down in her office at the University of California San Diego School of Medicine and considered a request from the other side of the world. Ghosh, a professor in the Departments of Medicine

Read More

No Comments InCovid-19